BioSpace News Archive

Massive Bio, Inc. , a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial enrollment, today announced it has successfully achieved Type 1 Service Organization Control (SOC 2 ® ) compliance examination for its flagship digital health platforms. The audit was performed by Control Logics, who have “i mplemented risk management methodologies and performed security assessments a

Medallia, Inc. (NYSE: MDLA), the global leader in experience management, today announced it has partnered with Veeva Systems, the leader in cloud-based software for the global life sciences industry. Medallia joined the Veeva Technology Partner Program to deliver a tightly integrated solution with Veeva CRM Suggestions that wi

The Froedtert & MCW health network has shown positive results by sending SilverCloud Health, the world’s leading digital mental health platform for healthcare systems and providers, to patients from their care team through Xealth, a leader in enabling digital health at scale.

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, today announced it will present a new 56 week analysis on patients who have been treated with pegzilarginase from the completed Phase 1/2 clinical trial and the ongoing Phase 2 open-label extension study in a late-breaking oral presentation at t

Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company” or “Therapix”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that it has closed a

VitaLink Research, a leading multi-therapeutic clinical trial network, has adopted the leading, fully-integrated eSource, eRegulatory and Clinical Trial Management System (CTMS) from Clinical Research IO (CRIO).

Asklepios BioPharmaceutical , Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced the appointment of Tim Trost as Chief Financial Officer. Mr. Trost is a highly accomplished CFO with more than 25 years of experience building, managing and financing emerging life sciences companies. Prior to joining AskBio, Mr. Trost most recently served as CFO at Chimerix (NASDAQ: CMRX), w

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will host a key opinion leader (KOL) call to discuss the unmet medical needs in suicide and depression on Tuesday, May 26, 2020 at 1:00 p.m. Eastern Time. The call will feature a discussion with Distinguished University Health Professor Emeritus at

OpenText™ (NASDAQ: OTEX) (TSX: OTEX) today announced Pathos Clinical Solutions, an independent, full service clinical laboratory, has selected OpenText™ EMR-Link™ for comprehensive EMR integration, Computurized Physician Order Entry (CPOE) and secure connectivity to clinicians.

CareCentrix, the leader in home-based and post-acute care services, announced today the addition of healthcare industry veteran Richard Popiel, MD, MBA to its Strategic Advisory Board.